Bristol Myers Squibb

September 30

FDA Approves First New Drug for Schizophrenia in Decades 

Bristol Myers Squibb (BMS) recently received U.S. Food & Drug Administration approval for COBENF ...

March 27

Bristol Myers Squibb Research Hitches Second Ride to Space Station

Bristol Myers Squibb recently sent a second biotherapeutics experiment from its New Jersey research ...

March 3

Bristol Myers Squibb Named to 2023 World’s Most Innovative Companies List

Bristol Myers Squibb, a global pharmaceutical giant with a large corporate presence in New Jersey, h ...

November 8

128 NJ Students Named Governor’s STEM Scholars

The Governor’s STEM Scholars on Tuesday announced their 2022-2023 class, made up of 128 high school ...

July 21

BMS Aims to Boost Disability Diversity in Clinical Trials

Bristol Myers Squibb this week announced the launch of its Disability Diversity in Clinical Trials ( ...

May 2

BMS Wins FDA Approval for Drug to Treat Rare Form of Cardiac Disease

The U.S. Food & Drug Administration has granted approval to Bristol Meyers Squibb’s drug Camzyos ...

February 10

BMS Awards $8 Million in Health Equity Grants to Improve Access to Care

Bristol Myers Squibb this week announced $7.965 million in new health equity grants to 24 U.S. nonpr ...